BAF180 CD4+ T cell Clear cell renal cell carcinoma RRM SWI/SNF T cell exhaustion

Journal

American journal of cancer research
ISSN: 2156-6976
Titre abrégé: Am J Cancer Res
Pays: United States
ID NLM: 101549944

Informations de publication

Date de publication:
2021
Historique:
received: 04 09 2021
accepted: 12 10 2021
entrez: 12 1 2022
pubmed: 13 1 2022
medline: 13 1 2022
Statut: epublish

Résumé

About 40% of clear cell renal cell carcinoma (ccRCC) cases carry the

Identifiants

pubmed: 35018236
pmc: PMC8727810

Types de publication

Journal Article

Langues

eng

Pagination

5965-5978

Informations de copyright

AJCR Copyright © 2021.

Déclaration de conflit d'intérêts

None.

Références

Science. 2018 Feb 16;359(6377):801-806
pubmed: 29301960
Epigenetics Chromatin. 2019 Nov 13;12(1):68
pubmed: 31722744
Nature. 2013 Sep 19;501(7467):338-45
pubmed: 24048066
Am J Cancer Res. 2017 Nov 01;7(11):2275-2289
pubmed: 29218250
Aging (Albany NY). 2020 Dec 19;13(3):3518-3535
pubmed: 33411689
Nat Protoc. 2008;3(6):1101-8
pubmed: 18546601
Oral Dis. 2021 Mar;27(2):204-214
pubmed: 32640108
Onco Targets Ther. 2019 Apr 30;12:3267-3275
pubmed: 31118677
Nat Rev Urol. 2018 Oct;15(10):599-614
pubmed: 30030490
Methods Mol Biol. 2014;1164:33-8
pubmed: 24927833
Kidney Int. 2009 Nov;76(9):939-45
pubmed: 19657325
Int J Mol Sci. 2019 Apr 04;20(7):
pubmed: 30987368
Oncol Lett. 2019 May;17(5):4321-4328
pubmed: 30988807
Science. 2018 Feb 16;359(6377):770-775
pubmed: 29301958
Am J Transl Res. 2016 Feb 15;8(2):742-8
pubmed: 27158366
Front Genet. 2021 Mar 12;12:628758
pubmed: 33868369
IUBMB Life. 2020 Jun;72(6):1175-1188
pubmed: 32073734
Biomed Pharmacother. 2021 Jan;133:110996
pubmed: 33227712
Biochim Biophys Acta. 2004 Jun 1;1699(1-2):1-34
pubmed: 15158709
Cancer Res. 2010 Mar 15;70(6):2538-47
pubmed: 20215511
Sci Rep. 2019 Sep 13;9(1):13238
pubmed: 31519977
Nat Med. 2017 Jul;23(7):869-877
pubmed: 28553932
Mol Cell. 2017 Apr 20;66(2):206-220.e9
pubmed: 28416140
Chem Rev. 2003 Jun;103(6):2167-201
pubmed: 12797828
Nat Genet. 2003 Aug;34(4):440-5
pubmed: 12858174
Trends Plant Sci. 2016 Jul;21(7):594-608
pubmed: 26920655
Clin Cancer Res. 2007 Aug 15;13(16):4740-9
pubmed: 17699851
Front Oncol. 2021 Aug 10;11:712765
pubmed: 34447697
Eur Urol. 2005 Oct;48(4):593-600
pubmed: 15964127
Mol Cancer Ther. 2021 Apr;20(4):655-664
pubmed: 33536192
Nature. 2013 Jul 4;499(7456):43-9
pubmed: 23792563
PLoS One. 2013 Sep 16;8(9):e74250
pubmed: 24066126
Cell Rep. 2017 Mar 21;18(12):2893-2906
pubmed: 28329682
Cancers (Basel). 2021 Aug 18;13(16):
pubmed: 34439305
Cell. 2011 Apr 29;145(3):435-46
pubmed: 21529715
Nat Commun. 2020 May 1;11(1):2135
pubmed: 32358509
Oncol Lett. 2011 Jul;2(4):591-597
pubmed: 22848233
Cancer Drug Resist. 2020 Jul 02;3(3):454-471
pubmed: 35582435
Annu Rev Biochem. 2006;75:681-706
pubmed: 16756507
IUBMB Life. 2020 Jun;72(6):1220-1232
pubmed: 32250548
Eur Urol Focus. 2017 Oct;3(4-5):421-427
pubmed: 28753773
Cell. 2012 May 25;149(5):1023-34
pubmed: 22632967
Radiol Bras. 2015 May-Jun;48(3):166-74
pubmed: 26185343
Cancer Cell Int. 2020 Dec 7;20(1):587
pubmed: 33372599

Auteurs

Joanna Szarkowska (J)

Department of Experimental Immunotherapy, Maria Sklodowska-Curie National Research Institute of Oncology Warsaw, Poland.

Pawel Cwiek (P)

Institute of Biochemistry and Biophysics, Polish Academy of Sciences Warsaw, Poland.

Michal Szymanski (M)

Department of Urology and Urological Oncology, Central Clinical Hospital of Ministry of the Interior and Administration in Warsaw Warsaw, Poland.

Natalia Rusetska (N)

Department of Experimental Immunotherapy, Maria Sklodowska-Curie National Research Institute of Oncology Warsaw, Poland.

Iga Jancewicz (I)

Department of Experimental Immunotherapy, Maria Sklodowska-Curie National Research Institute of Oncology Warsaw, Poland.

Malgorzata Stachowiak (M)

Department of Experimental Immunotherapy, Maria Sklodowska-Curie National Research Institute of Oncology Warsaw, Poland.

Monika Swiatek (M)

Department of Experimental Immunotherapy, Maria Sklodowska-Curie National Research Institute of Oncology Warsaw, Poland.

Maciej Luba (M)

Department of Experimental Immunotherapy, Maria Sklodowska-Curie National Research Institute of Oncology Warsaw, Poland.

Ryszard Konopinski (R)

Department of Experimental Immunotherapy, Maria Sklodowska-Curie National Research Institute of Oncology Warsaw, Poland.

Szymon Kubala (S)

Institute of Biochemistry and Biophysics, Polish Academy of Sciences Warsaw, Poland.

Renata Zub (R)

Department of Experimental Immunotherapy, Maria Sklodowska-Curie National Research Institute of Oncology Warsaw, Poland.

Jakub Kucharz (J)

Department of Uro-oncology, Maria Sklodowska-Curie National Research Institute of Oncology Warsaw, Poland.

Pawel Wiechno (P)

Department of Uro-oncology, Maria Sklodowska-Curie National Research Institute of Oncology Warsaw, Poland.

Janusz A Siedlecki (JA)

Department of Molecular and Translational Oncology, Maria Sklodowska-Curie National Research Institute of Oncology Warsaw, Poland.

Sergiusz Markowicz (S)

Department of Experimental Immunotherapy, Maria Sklodowska-Curie National Research Institute of Oncology Warsaw, Poland.

Elzbieta Sarnowska (E)

Department of Experimental Immunotherapy, Maria Sklodowska-Curie National Research Institute of Oncology Warsaw, Poland.

Tomasz J Sarnowski (TJ)

Institute of Biochemistry and Biophysics, Polish Academy of Sciences Warsaw, Poland.

Classifications MeSH